Dear Shareholders I am pleased to report that Biotron is in the final stage of three Phase 2 clinical trials for HIV‐1 and COVID‐19. This is a pivotal time for the Company as it completes data collection and analyses of samples and information collected during the trials ahead of the release of headline data in the coming weeks.
I like the wording "Release of headline data"
Ann: Letter to Shareholders, page-3
-
- There are more pages in this discussion • 379 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.14M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.9¢ | $7.664K | 403.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 1202498 | 5 |
View Market Depth
| Last trade - 13.42pm 27/09/2024 (20 minute delay) ? |
| BIT (ASX) Chart |